{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:14:48Z","timestamp":1778883288936,"version":"3.51.4"},"reference-count":34,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuklearmedizin"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aim\u2002The objective of this study was to assess the impact of implementing FDG-PET imaging in treatment algorithms for differentiated thyroid cancer with suspected recurrence. Primary end points were overall, event-free and disease-specific survival. Secondary end points were therapies, disease control and the sensitivity and specificity of PET imaging.<\/jats:p><jats:p>Methods\u2002194 patients with DTC treated at our center from 1996 to 2014 following thyroidectomy and routine 131I ablation with no remaining 131I uptake in whole-body scans but persisting or rising thyroglobulin values were enrolled in this retrospective analysis. Of these, 149 (76.8\u200a%) received an 18F-FDG scan (PET group) whereas the remaining 45 patients (23.2\u200a%) did not (non-PET group). Survival, disease-specific characteristics at inclusion, disease control and therapies were compared.<\/jats:p><jats:p>Results\u2002Patients of the PET group generally showed characteristics associated with higher disease activity from inclusion onwards. This did not translate to statistically significant differences in survival. If PET imaging was performed following inclusion, patients received significantly less radioiodine treatments during the first nine months after inclusion (63.1\u200a% of the PET-group vs 82.2\u200a% of the non-PET group). Simultaneously, patients tended to receive more surgeries following PET imaging (27.5\u200a% PET-group vs 13.3\u200a% non-PET group). No significant differences regarding disease control were observed.<\/jats:p><jats:p>Conclusion\u2002The early use of FDG-PET imaging in cases of suspected recurrence or existence of dedifferentiated DTC can lead to changes in therapy management, specifically identifying patients unlikely to benefit from additional radioiodine therapy who would instead qualify for surgical therapy methods.<\/jats:p>","DOI":"10.1055\/a-1177-9728","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T22:59:22Z","timestamp":1592261962000},"page":"356-364","source":"Crossref","is-referenced-by-count":6,"title":["Impact of FDG-PET on therapy management and outcome of\u00a0differentiated thyroid carcinoma patients with elevated thyroglobulin despite negative iodine scintigraphy"],"prefix":"10.1055","volume":"59","author":[{"given":"Philipp","family":"Backhaus","sequence":"first","affiliation":[{"name":"University Hospital M\u00fcnster, Nuclear Medicine, Albert-Schweizer-Campus 1, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Vrachimis","sequence":"first","affiliation":[{"name":"University Hospital M\u00fcnster, Nuclear Medicine, Albert-Schweizer-Campus 1, M\u00fcnster, Germany"},{"name":"Current address: Department of Nuclear Medicine, German Oncology Center, University Hospital of the\u00a0European University, Limassol, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Carolin","family":"Schleupner","sequence":"additional","affiliation":[{"name":"University of M\u00fcnster Faculty of Medicine, M\u00fcnster, Nordrhein-Westfalen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Riemann","sequence":"additional","affiliation":[{"name":"University Hospital M\u00fcnster, Nuclear Medicine, Albert-Schweizer-Campus 1, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sch\u00e4fers","sequence":"additional","affiliation":[{"name":"University Hospital M\u00fcnster, Nuclear Medicine, Albert-Schweizer-Campus 1, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12149-011-0545-4","article-title":"Can (18)F-FDG-PET\/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?","volume":"26","author":"P Bannas","year":"2012","journal-title":"Ann Nucl Med"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cpet.2014.12.009","article-title":"Value of Fluorodeoxyglucose PET\/Computed Tomography Patient Management and Outcomes in Thyroid Cancer","volume":"10","author":"A Ciarallo","year":"2015","journal-title":"PET Clin"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1677\/ERC-10-0233","article-title":"Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?","volume":"18","author":"D Deandreis","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"02","key":"ref4","first-page":"1010","article-title":"What is the role of florine-18 fluorodeoxyglucose\/positron emission tomography\/computed tomography imaging in well-differentiated thyroid cancers with negative iodine-131 scan high thyroglobulin and normal anti-thyroglobulin levels","volume":"12","author":"R K Doner","year":"2016","journal-title":"J Cancer Res\u00a0Ther"},{"issue":"08","key":"ref5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/MNM.0b013e32832dcfa7","article-title":"Value of 18F-FDG-PET\/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a\u00a0meta-analysis","volume":"30","author":"M J Dong","year":"2009","journal-title":"Nucl Med Commun"},{"issue":"09","key":"ref6","first-page":"1468","article-title":"Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer","volume":"37","author":"U Feine","year":"1996","journal-title":"J Nucl Med"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1245\/s10434-007-9611-5","article-title":"Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET\/CT) for detection of recurrent, 131I-negative thyroid cancer","volume":"15","author":"S E Finkelstein","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1160\/nukmed-0288","article-title":"Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer","volume":"46","author":"C Franzius","year":"2007","journal-title":"Nuklearmedizin"},{"issue":"05","key":"ref9","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/hed.21791","article-title":"Relationship between serum thyroglobulin and 18FDG-PET\/CT in 131I-negative differentiated thyroid carcinomas","volume":"34","author":"L Giovanella","year":"2012","journal-title":"Head Neck"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/0284185115594645","article-title":"F18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis","volume":"57","author":"T Haslerud","year":"2016","journal-title":"Acta Radiol"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cncr.30360","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?","volume":"123","author":"B R Haugen","year":"2017","journal-title":"Cancer"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/thy.2016.0628","article-title":"American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features","volume":"27","author":"B R Haugen","year":"2017","journal-title":"Thyroid"},{"issue":"04","key":"ref13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3413\/Nukmed-0541-12-11","article-title":"Distant metastatic lesions in patients with differentiated thyroid carcinoma. Clinical implications of radioiodine and FDG uptake","volume":"52","author":"C M Hong","year":"2013","journal-title":"Nuklearmedizin"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/hed.24967","article-title":"Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography in patients with recurrent papillary thyroid cancer","volume":"40","author":"J H Kang","year":"2018","journal-title":"Head Neck"},{"issue":"282","key":"ref15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric Estimation from Incomplete Observations","volume":"53","author":"E L Kaplan","year":"1958","journal-title":"Journal of the American Statistical Association"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s13139-013-0249-x","article-title":"Expression patterns of glucose transporter-1 gene and thyroid specific genes in human papillary thyroid carcinoma","volume":"48","author":"S Kim","year":"2014","journal-title":"Nucl Med Mol Imaging"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ncpendmet0402","article-title":"The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers","volume":"3","author":"S Leboulleux","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"08","key":"ref18","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2967\/jnumed.112.117119","article-title":"Clinical utility of 18F-FDG PET\/CT concurrent with 131I therapy in intermediate-to-high-risk patients with differentiated thyroid cancer: dual-center experience with 286 patients","volume":"54","author":"J W Lee","year":"2013","journal-title":"J Nucl Med"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/1754-9485.12286","article-title":"Fluorodeoxyglucose positron emission tomography\/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival","volume":"59","author":"C Marcus","year":"2015","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12149-011-0536-5","article-title":"Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level","volume":"26","author":"S J Na","year":"2012","journal-title":"Ann Nucl Med"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12149-013-0801-x","article-title":"Diagnostic value of 18F-FDG PET\/CT in patients with TENIS syndrome: correlation with thyroglobulin levels","volume":"28","author":"E Ozdemir","year":"2014","journal-title":"Ann Nucl Med"},{"issue":"06","key":"ref22","first-page":"315","article-title":"Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels","volume":"31","author":"V M Pachon-Garrudo","year":"2012","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"04","key":"ref23","first-page":"616","article-title":"Integrated PET\/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management","volume":"47","author":"H Palmedo","year":"2006","journal-title":"J Nucl Med"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/MNM.0000000000000350","article-title":"Value of 18F-FDG PET negativity and Tg suppressibility as markers of prognosis in patients with elevated Tg and 131I-negative differentiated thyroid carcinoma (TENIS syndrome)","volume":"36","author":"R Ranade","year":"2015","journal-title":"Nucl Med Commun"},{"issue":"02","key":"ref25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/jc.2005-1534","article-title":"Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning","volume":"91","author":"R J Robbins","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"09","key":"ref27","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00259-012-2065-4","article-title":"(18)F-FDG PET\/CT changes therapy management in high-risk DTC after first radioiodine therapy","volume":"39","author":"S J Rosenbaum-Krumme","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"03","key":"ref28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3413\/Nukmed-0766-15-09","article-title":"Initial [18F]FDG PET\/CT in high-risk DTC patients. A three-year follow-up","volume":"55","author":"M Ruhlmann","year":"2016","journal-title":"Nuklearmedizin"},{"issue":"42","key":"ref29","doi-asserted-by":"crossref","first-page":"e8344","DOI":"10.1097\/MD.0000000000008344","article-title":"Prognostic role of FDG PET\/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy","volume":"96","author":"B Salvatore","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/856189","article-title":"The role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overview","volume":"856189","author":"G Treglia","year":"2013","journal-title":"Int J Endocrinol"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/RLU.0b013e31825b2057","article-title":"Prognostic significance of FDG PET\/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data","volume":"3","author":"G U Vural","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"09","key":"ref32","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1089\/thy.2015.0062","article-title":"Evaluating Positron Emission Tomography Use in Differentiated Thyroid Cancer","volume":"25","author":"J L Wiebel","year":"2015","journal-title":"Thyroid"},{"issue":"02","key":"ref33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/RLU.0b013e318203bb6c","article-title":"The local efficacy of I-131 for F-18 FDG PET positive lesions in patients with recurrent or metastatic thyroid carcinomas","volume":"36","author":"K Yoshio","year":"2011","journal-title":"Clin Nucl Med"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"W J Youden","year":"1950","journal-title":"Cancer"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00259-006-0276-2","article-title":"Combined PET\/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality?","volume":"34","author":"M Zoller","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Nuklearmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1177-9728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T12:34:37Z","timestamp":1616243677000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1177-9728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":34,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2020,9,28]]},"published-print":{"date-parts":[[2020,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1177-9728","relation":{},"ISSN":["0029-5566","2567-6407"],"issn-type":[{"value":"0029-5566","type":"print"},{"value":"2567-6407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]}}}